OVARIAN CLUB II
The fertilization process of the oocyte and embryo development in relation to various clinical conditions
Dorint Hotel Don Giovanni, Prague, Czech Republic November 8-11, 2012
A unique event that will create synergies between basic science, research and daily clinical practice to benefit patient care

Home
Welcome Note
Committee
Timetable & Program
Timetable
Scientific Program
Club Speakers
Meet the Speakers
Registration & Accommodation
Registration
Accommodation
Dorint Hotel Don Giovanni
Invitation Letter
Meeting Information
Posters Presentations
Group A Posters
Group B Posters
Posters Presentation Guide
Your arrival to Prague
Guidelines for Speakers
CME
General Information
Partners & Links
About Prague
NewsLetter History
OVARIAN CLUB 2011
Sponsors
  Scientific Program Print
______________________________________________

Thursday, November 8, 2012
 
14:30-16:30
SESSION 1:
Harvesting and Harnessing Human Ovarian Stem Cells
Supported by an unrestricted grant by IBSA
Chairpersons: Carlos Simón, Spain; Zeev Shoham, Israel; Gerald Schatten, USA

14:30-15:00

Isolation and characterization of OSCs in human
Jonathan Tilly
, USA
 

15:00-15:30

Formation of new human follicles from OSCs in vitro
Evelyn Telfer, UK
 

15:30-16:00

Testing genetic integrity of OSC formed oocytes
David Albertini, USA
 

16:00-16:30

Modulation of Mouse Oogonial Stem Cell Fate Determination by Long-term Propagation
Dori Woods, USA
 
16:30-17:00
Coffee Break/ Poster Viewing
17:00-19:00
SESSION 2:
The Mystery of Fertility Preservation
Chairpersons: Sherman Silber, USA; Kenneth Korach, USA

17:00-17:30

The oocytes as the conductor of the reproductive symphony
Pasquale Patrizio
, USA
 

17:30-18:00

Directional freezing or vitrification; which child do I prefer?
Amir Arav
, Israel
 

18:00-18:30

Vitrification- as applied embryos and ovaries
Sherman Silber
, USA
 

18:30-19:00

Oocyte Cryopreservation for Cancer and Deferred Reproduction
Nicole Noyes
, USA
 
 
19:00
 
Ovarian Club Meet & Greet


Friday, November 9, 2012


08:30-10:30
SESSION 3:
Recruitment, follicular development and oocyte competence
Supported by an unrestricted grant by IBSA
Chairpersons: Evelyn Telfer, UK; Jeremy Thompson, Australia; Ariel Hourvitz, Israel

08:30-09:00

Molecular characterization of human folliculogenesis and ovulatory events - from basic research to clinical application
Ariel Hourvitz, Israel
 
 09:00-09:30
What granulosa cell- and oocyte-specific ARKO mice can tell us about folliculogenesis and female fertility
Aritro Sen, USA
 

09:30-10:00

CHK1 is involved in SAC satisfaction and preservation of DNA integrity in mouse oocytes
Jan Motlik, Czech Republic
 
10:00-10:30
 
Appropriate meiotic segregation in oocytes: possible practical implications
Nava Dekel, Israel
 
10:30-11:00
Coffee Break/ Poster Viewing
11:00-13:00
SESSION 4:
The Environmental Influence of Oocytes and Embryos
Chairpersons: Satish Gupta, India; Patrick Quinn, USA; Maurizio Dattilo, Italy
11:00-11:30
Environmental Action on Ovarian toxicity
Kenneth Korach, USA
 
11:30-12:00
Environmental exposures and gametogenesis: are exposures affecting our reproductive health?
Patricia Hunt, USA 
 
12:00-12:30
Late procreation in the main determinant of multiple pregnancies
Piergiorgio Crosignani, Italy
 
12:30-13:00
Relationship of telomere length in human gametes and zygotes with semen analysis parameters, sperm DNA fragmentation, smoking status and treatment outcome: What are the clinical implications of telomere length for embryo viability?
Geraldine Hartshorne, UK
 
13:00-13:45
Lunch Break
 
 
13:45-14:15
 
New Horizons: The Voice of the Industry
Company symposium sponsored by Abbott
 
Abbott's Research Activities in IVF

Julian V. Platon, MD, PhD
Global Medical Director, Gastrointestinal & Women Health
Strategic Medical Affairs
Abbott Products Operations AG, Basel, CH
14:15-15:45
SESSION 5:
Oocytes and Embryos: Clinical Relevance
Chairpersons: Shevach Friedler, Israel; Denny Sakkas, USA;
Marcos Meseguer, Spain
14:15-14:45
In Vitro Maturation does not offer any advantage over current IVF for PCOS patients
Samir Hamamah, France
 
14:45-15:15
Alterations in oocyte, embryo and/or endometrium quality in endometriosis: identifying the weak link
Dominique De Ziegler, France
 

15:15-15:45

Ovarian stimulation for IVF , the oocyte and the embryo: possible detrimental effects
Esther B. Baart , The Netherlands
 
15:45-16:15
Coffee Break/ Poster Viewing
16:15-18:15
SESSION 6:
Biomarkers: Clinical Relevance
Endorsed by IVI
Chairpersons: Carlos Simón, Spain; Samir Hamamah, France; Maria Lalioti, USA
16:15-16:35
Polymorphisms as biomarkers of ovarian reserve and oocyte quality
Maria Lalioti, USA
 
16:35-16:55
Cumulus cells as markers of oocyte and embryo quality
Emre Seli, USA
 
16:55-17:15
Clinical relevance of morphokinetics to assess embryo viability
Marcos Meseguer, Spain
 
17:15-17:35
Non invasive metabolomic profiling of embryos using spectroscopy
Denny Sakkas, USA
 

17:35-17:55

Use of Comparative Genomic Hybridization (CGH) for embryo assessment. Clinical results
Carmen Rubio, Spain
 

17:55-18:15

Conclusion
Carlos Simón, Spain
 
18:15
Ovarian Club Meet & Greet

Saturday, November 10, 2012

08:30-10:30
SESSION 7:
Clinical implication of ICSI failure
Supported by an unrestricted grant by IBSA
Chairpersons: Nicole Noyes, USA; Jonathan Van Blerkom, USA
08:30-09:00
The sperm-egg, fertilization and the embryo: Egg activation - calcium oscillations and outcome in pre and post implantation development
Jean-Pierre Ozil, France
 
09:00-09:30
The mechanisms of mammalian sperm-egg interaction
John C. Herr
, USA
 
09:30-10:00
Cell cycle control in human embryos: Why all the aneuploidy?
David Albertini
, USA
 

10:00-10:30

Post-transciptional regulations during oocyte-to-zygote transition
Petr Svoboda , Czech Republic
 
10:30-11:00
Coffee Break/ Poster Viewing
11:00-13:00
SESSION 8:
Metabolic programming during the preconception period and implications for subsequent fetal, neo-natal and adult health
Chairpersons: Ellen Anckaert, Belgium; David Albertini, USA

11:00-11:30

Preconception protein levels and subsequent fetal growth
Tom Fleming, UK
 
11:30-12:00
Cellular disruption within oocytes and early embryos caused by maternal diabetes – basic and clinical implications
Kelle H. Moley, USA
 
12:00-12:30
O-linked glycosylation mediates the hyperglycemic pathology in oocytes and early embryos?
Jeremy Thompson, Australia
 
12-30-13:00
Dietary methyl donors during the preconception period and their influence on subsequent development
Kevin Sinclair, UK
 
13:00-13:45
Lunch Break
 
 
 13:45-14:15
 
New Horizons: The Voice of the Industry
Company symposium sponsored by Ferring 
 
Why Health Care Professionals and Pharma Must Work Together to Identify and Meet Patients’ Needs
 
Julian Jenkins, DM, FRCOG
Head of Global Medical Affairs
Ferring International Center SA,
St. Prex, Switzerland
 
14:15-16:15
SESSION 9:
The Fertilization Process
Chairpersons: Norbert Gleicher, USA; Gwo-Jang Wu, Taiwan;
Jan Motlik, Czech Republic

14:15-14:45

Membrane and cytoplasmic influences on penetration and post penetration development-- can basic science provide markers for the clinical embryologist
Jonathan Van Blerkom, USA
 

14:45-15:15

Role of Chromatin Remodeling Proteins in Chromosome Segregation and the Transmission of Aneuploidy in Mammalian Oocytes. Basic research with clinical implications
Rabindranath De La Fuente, USA
 

15:15-15:45

The Minimal Oocyte – or How to construct an artificial egg? what are the requirements for the oocyte to achieve it mission
Gerald Schatten, USA
 

15:45-16:15

Human Tubal Fluid: In Vivo and In Vitro
Patrick Quinn, USA
 
16:15-16:45
Coffee Break/ Poster Viewing
16:45-18:45
SESSION 10:
Aging
Chairpersons: Dominique De Ziegler, France; Piergiorgio Crosignani, Italy;
Zeev Shoham, Israel

16:45-17:15

How androgens and genes affect follicle maturation and ovarian aging
Norbert Gleicher, USA
 

17:15-17:45

How do Oocytes Tell Time? (Oocyte Aging and Can the Chronology Sensing Machinery Be Reset)
Gerald Schatten, USA
 

17:45-18:15

Female reproductive aging: new insights into an old problem
Mary Herbert,
UK
 

18:15-18:45

The impact of Y chromosome like regions of the X chromosome (palindromes and amplicons) on ovarian reserve
Sherman Silber, USA
 
 

Home    Contact Us   
Copyright © 2007 comtecmed.com. All rights reserved.   The website was last updated on 02/20/2013 Created by     WebStudio.co.il